A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

This study has been completed.
Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			HIV Infections
			Cancer
			Pain
2		Additional conditions recognized in this trial
			Acquired Immunodeficiency Syndrome
			Infection
3		More general conditions related to this trial
			Immune System Diseases
			Immunologic Deficiency Syndromes
			Lentivirus Infections
			Retroviridae Infections
			RNA Virus Infections
			Sexually Transmitted Diseases
			Sexually Transmitted Diseases, Viral
			Slow Virus Diseases
			Virus Diseases
4		Interventions listed in this trial
			Ziconotide
5		More general drug interventions related to this trial
			Analgesics
			Analgesics, Non-Narcotic
			Calcium Channel Blockers
			Cardiovascular Agents
			Central Nervous System Agents
			Membrane Transport Modulators
			Molecular Mechanisms of Pharmacological Action
			Neuroprotective Agents
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Protective Agents
			Sensory System Agents
			Therapeutic Uses
6		Sponsors listed in this trial
			Neurex